Wednesday, 7 October 2026
7 October 2026
- In brief
- 1Flu is rising about a month early in the US West, with a changed strain, and experts disagree on whether the season is unusual
- 2Kenya records its first Ebola death
- 3Russia says little about a plague-lab death
- 4A million Britons vape who never smoked
- 5Doctors argue over a blood test for many cancers
- 6Oxygen clips drifted from too high to too low
- 7A US health survey may drop disability questions
- 8The WHO sets out care for children with obesity
- 9Hospitals sell longevity check-ups
- 10Why a hangover can bring a morning of dread
- 11Ten mental health trusts reported over bedroom cameras
- 12Calls for an inquiry into Northern Ireland's smear tests
- 13Health costs tie with petrol as US voters' worry
- 14Guides kept new mothers in care
- 15Knee shape and torn ligaments
- 16Overfed baby mice lost muscle faster in old age
- 17Cardiac arrest survival lagged in Fukushima
- 18A cold rinse eased pain after root canals
- 19Planted documents steered AI health answers
- 20Smokers needed more surgery for golfer's elbow
- 21AI home exercise for Parkinson's showed no clear gain
7 Oct · Mind & body · In brief
Mind & body · Wednesday, 7 October 2026
Mind & body, in brief
21 stories · 44 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 4
Officials saying little
Russia has said little about why a worker at a plague laboratory in Siberia died, and the WHO's chief asked it for complete information.
What is moving · 2 of 4
Germs crossing borders
A Kenyan man with Ebola travelled from Congo by road and plane to Nairobi, Kenya's capital, and died there.
What is moving · 3 of 4
Health checks that misread
Clips that read blood oxygen through a finger drifted from reading too high to too low over five years at one US hospital.
What is moving · 4 of 4
Selling to people who are not ill
US hospitals are selling longevity check-ups, to people who want to age more slowly, for $5,500 to $45,000.
Part of the day's signal
One pressure seen across the day runs through Mind & body too.
21 stories
12 sources
Mind & body, in brief
- 1An early start to flu season moves up vaccination timing
- 2Deciding when to get your flu shot? Consider these factors
- 12Kenya confirms first Ebola case as virus 'surges' in DR Congo province
- 14Plague epidemic risk in Russia low after death of lab technician, WHO says
- 20A plague research employee in Russia died from an unknown cause. Here's what we know
- 21Proportion of people in Great Britain vaping who never smoked doubles in four years
- 23Blood test for multiple cancers clears crucial hurdle on track to FDA approval
- 24FDA advisory panel to vote on a multi-cancer blood test
- 25Taxpayers shouldn't pay for an ineffective multi-cancer screening test
- 26New study finds pulse oximeters don't accurately track blood oxygen
- 28As CDC redesigns annual health survey, it removes questions about disabilities
- 35Family of woman who died after 'misread' smear test join calls for inquiry
Flu is rising about a month early in the US West, with a changed strain, and experts disagree on whether the season is unusual
Swipe up for the story ↑Scroll down for the story ↓
Flu began rising about a month early this autumn in the US West, in California, Washington, Hawaii and Alaska, rather than in the South, where US seasons usually start.
the strain had changed after the shot was chosen
the WHO estimates 290,000 to 650,000, out of about a billion cases a year
Who is involved
Caitlin Rivers
an epidemiologist at Johns Hopkins University who tracks how diseases spread; she says flu has come early
Who is involved
Alex Greninger
head of infection testing at the University of Washington in Seattle; his labs see Christmas levels of flu now
Why it matters
Watch whether flu starts rising outside the West in the CDC's weekly counts; that would turn an early start in a few states into an early season for the whole country.
How it works
What a treatment is worth depends on the risk it takes away
How it works
A vape helps a smoker and only adds danger for someone who never smoked, and a cancer test or a flu shot does most good where the risk is highest.
How it works · step 1 of 5
Every shot, test or product has costs and side effects for everyone who uses it
How it works · step 2 of 5
What it gives back is the harm it prevents
How it works · step 3 of 5
Someone at high risk has a lot of harm for it to prevent
How it works · step 4 of 5
Someone at low risk has little, but pays the same costs
How it works · step 5 of 5
So the same thing can help one person on balance and harm another
The twist
A vape, a cancer blood test or a flu shot does not have one value: each is worth most to the people with the most danger for it to take away.
The picture
The same vape in two people. For the smoker it replaces cigarettes; for the person who never smoked it replaces nothing.
Seen the same day
A vape helps a smoker because it replaces cigarettes, but a person who never smoked has no cigarette risk for it to remove, only the vape's own.
Seen the same day
A researcher says the test may help people at high cancer risk, while people at low risk mostly face false alarms and the scans and biopsies that follow.
Seen the same day
The new mRNA flu shot was approved for people over 50, and older adults were most of those in hospital with flu in Europe last winter, so a shot prevents the most harm in them.
The catch
A person's own risk is often hard to know in advance, and it can be higher or lower than their group's, so the line between who gains and who loses is blurry.
The whole
The regulator approving a test, the doctor offering it and the person taking it each see a different part of the same sum.
The whole
Each of us stands somewhere on that scale of risk, usually without knowing exactly where.
Who gains
Moderna
Its mFLUSIVA is the first mRNA flu shot on the US market, approved for everyone aged 50 and over.
Nobody knows yet
Whether this US flu season is unusual.
Johns Hopkins and University of Washington experts call the start early and odd, while Michael Osterholm calls it a normal year so far and national CDC data show little flu outside the West.
Nobody knows yet
How well this winter's shots match the new variant seen in Seattle.
The strains were picked in February, the variant has not been named in what we could read, and last winter's mismatched shot still cut adults' hospital risk by about 30%.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
Michael Osterholm
head of an infectious disease centre at the University of Minnesota; he calls it a normal start so far
Part 1 of 13 · Who else is involved
The CDC
the US national disease agency, run under health secretary Robert F. Kennedy Jr.; it has not been promoting flu shots
Part 2 of 13 · How it unfolded
Feb 2026
The WHO picks the strains for this winter's flu shots
Sept 2026
Positive flu tests start climbing in the US West
Part 2 of 13 · How it unfolded
Sept 2026
Positive flu tests start climbing in the US West
6 Oct
Experts disagree on whether the early start is unusual
Part 3 of 13
The share of people testing positive has climbed since early September, and flu visits to emergency rooms have crept up for weeks, says Caitlin Rivers, an epidemiologist at Johns Hopkins University.
Part 4 of 13
At the University of Washington in Seattle, doctors are seeing as much flu now as they usually see around Christmas, says Alex Greninger, who runs infection testing there.
Part 5 of 13
Much of that flu is a new variant with a mutation that seems to help it slip past the body's defences, Greninger says.
Part 6 of 13
Not every expert calls this unusual.
Part 6 of 13
Michael Osterholm of the University of Minnesota calls it a pretty normal flu year so far, and national CDC data still show little flu across most of the country.
Part 7 of 13
Flu changes a little all the time, and the body's antibodies, built from earlier infections and shots, fit each changed version less well.
Part 8 of 13
Last winter a changed H3N2 strain called subclade K, first seen in August 2025, started seasons early in Japan, Hong Kong and the UK.
Part 8 of 13
Europe's season began about four weeks early, and adults aged 65 and over were most of those sick enough for hospital.
Part 9 of 13
That strain arrived after the year's vaccine had been chosen.
Part 9 of 13
In the US the shot still cut the risk of a flu hospital stay by 41% in children and about 30% in adults.
Part 10 of 13
For this winter the WHO updated the shots in February to newer strains, including a new H3N2.
Part 10 of 13
US vaccines follow a choice an FDA panel made in March.
Part 11 of 13
In August the FDA, the US medicines regulator, approved Moderna's mFLUSIVA, the first flu vaccine made with mRNA, for people aged 50 and over.
Part 11 of 13
In adults aged 50 to 64 it cut confirmed flu by 27% against a standard shot.
Part 12 of 13
An mRNA shot can be made faster than vaccines grown in eggs, so its strains could be picked closer to the season, after a surprise variant has shown itself.
Part 12 of 13
In an April 2025 poll, most Americans over 50 said they did not know if mRNA vaccines are safe.
Part 13 of 13
The CDC, the US national disease agency, has not been promoting flu shots as it usually does, under health secretary Robert F.
Part 13 of 13
Kennedy Jr., a long-time vaccine critic.
Part 13 of 13
The CDC says it is preparing messages on the benefits and risks of a shot.
11 sources
Flu is rising about a month early in the US West, with a changed strain, and experts disagree on whether the season is unusual
- 1An early start to flu season moves up vaccination timing
- 2Deciding when to get your flu shot? Consider these factors
- 3Recommendations for influenza vaccine composition for the 2026-2027 northern hemisphere season
- 4Flu season 2026: Welcome to the winter of subclade K
- 5More than half of WHO European Region experiencing intense, early influenza season driven by new strain
- 6Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026
- 7FDA approves flu shot based on technology RFK Jr. previously criticized
- 8FDA approves Moderna flu shot made with mRNA
- 9As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology's Safety | KFF Quick Takes
- 10The WHO just made its predictions for the 2026-2027 flu season
- 112026-2027 Flu Season
The full story
Flu is rising about a month early in the US West, with a changed strain, and experts disagree on whether the season is unusual
Flu began rising about a month early this autumn in the US West, in California, Washington, Hawaii and Alaska, rather than in the South, where US seasons usually start.
The share of people testing positive has climbed since early September, and flu visits to emergency rooms have crept up for weeks, says Caitlin Rivers, an epidemiologist at Johns Hopkins University.
At the University of Washington in Seattle, doctors are seeing as much flu now as they usually see around Christmas, says Alex Greninger, who runs infection testing there.
Much of that flu is a new variant with a mutation that seems to help it slip past the body's defences, Greninger says.
Not every expert calls this unusual. Michael Osterholm of the University of Minnesota calls it a pretty normal flu year so far, and national CDC data still show little flu across most of the country.
Flu changes a little all the time, and the body's antibodies, built from earlier infections and shots, fit each changed version less well.
Last winter a changed H3N2 strain called subclade K, first seen in August 2025, started seasons early in Japan, Hong Kong and the UK.
That strain arrived after the year's vaccine had been chosen. In the US the shot still cut the risk of a flu hospital stay by 41% in children and about 30% in adults.
For this winter the WHO updated the shots in February to newer strains, including a new H3N2.
In August the FDA, the US medicines regulator, approved Moderna's mFLUSIVA, the first flu vaccine made with mRNA, for people aged 50 and over.
An mRNA shot can be made faster than vaccines grown in eggs, so its strains could be picked closer to the season, after a surprise variant has shown itself.
The CDC, the US national disease agency, has not been promoting flu shots as it usually does, under health secretary Robert F. Kennedy Jr., a long-time vaccine critic.
Why it matters. Watch whether flu starts rising outside the West in the CDC's weekly counts; that would turn an early start in a few states into an early season for the whole country.
Kenya records its first Ebola death
Swipe up for the story ↑Scroll down for the story ↓
Kenya's health minister, Aden Duale, said on 6 October that a Kenyan man had died of Ebola in a Nairobi hospital, the country's first such death.
He had lived in the Democratic Republic of the Congo for seven years and fell ill there about a month ago.
He then travelled by road to Kampala, Uganda's capital, and flew to Nairobi on 3 October.
Officials listed 28 of his contacts and are looking for 23 passengers and four crew from his flight.
Why it matters
This outbreak is Ebola of the Bundibugyo type, which has no vaccine or specific medicine, and it has killed 4,082 of 8,463 confirmed patients in Congo since May.
Why it matters
The charity Medecins Sans Frontieres says Congo's North Kivu province now has 40% of new cases, up from 24% at the end of August.
Who pays
Families and health workers around the man who died in Nairobi
Twenty-eight of his contacts are being followed, and quarantine has been arranged for passengers from his flight found to be at risk.
Nobody knows yet
Whether Ebola spread on the flight to Nairobi.
Only the man who died has tested positive so far, and officials were still looking for 23 passengers and four crew.
Part of a signal
Dangerous germs crossing borders
Seen in 3 of the 12 beats
Also seen in World and Biotech.
The whole signal →2 sources
Kenya records its first Ebola death
The full story
Kenya records its first Ebola death
Kenya's health minister, Aden Duale, said on 6 October that a Kenyan man had died of Ebola in a Nairobi hospital, the country's first such death.
Why it matters. This outbreak is Ebola of the Bundibugyo type, which has no vaccine or specific medicine, and it has killed 4,082 of 8,463 confirmed patients in Congo since May.
Russia says little about a plague-lab death
Swipe up for the story ↑Scroll down for the story ↓
Darya Shipilova, 28, worked at the Irkutsk Anti-Plague Institute in Siberia and died on 2 October, two days after falling ill.
Russia's health watchdog calls it pneumonia of unknown cause, and told the WHO that no plague case was recorded in Irkutsk.
On 6 October the WHO rated the risk low for Russia and very low for Europe, and said none of her contacts had shown symptoms.
Its chief, Tedros Adhanom Ghebreyesus, still asked Russia for complete information.
Why it matters
Plague in the lungs, called pneumonic plague, can pass between people in coughed droplets, but antibiotics cure it if they start early.
Why it matters
Tests on a few contacts found only Covid and a common cold virus, and the WHO is asking whether a second worker is ill.
Why it matters
US Secretary of State Marco Rubio asked Russia to share more, and the CDC says it sees no wider threat to the US.
What's really going on
Russia has told the world little about why a worker at a Siberian plague laboratory died, and the head of the WHO has asked it for complete information.
Why it works on people
When officials say little, people assume the worst, and a biosecurity expert said Russia could calm fears simply by releasing basic facts such as the germ's genetic code.
Nobody knows yet
What killed Darya Shipilova.
Russia's watchdog says pneumonia of unknown cause and that tests found no germ linked to her work, while a regional leader first wrote that she died of plague and then edited it to possibly.
Good news
None of the people who had contact with the plague-lab worker who died in Siberia has shown any symptoms, the WHO said on 6 October.
6 sources
Russia says little about a plague-lab death
- 14Plague epidemic risk in Russia low after death of lab technician, WHO says
- 15Rubio urges Russia to share more information on plague lab worker's death
- 16What do we know about death of anti-plague institute worker in Russia and is there a wider risk?
- 17Panic is getting ahead of evidence on Russian 'plague' story
- 18CDC 'closely monitoring' suspected pneumonic plague case
- 19What is pneumonic plague and how does it spread?
The full story
Russia says little about a plague-lab death
Darya Shipilova, 28, worked at the Irkutsk Anti-Plague Institute in Siberia and died on 2 October, two days after falling ill.
Why it matters. Plague in the lungs, called pneumonic plague, can pass between people in coughed droplets, but antibiotics cure it if they start early.
A million Britons vape who never smoked
Swipe up for the story ↑Scroll down for the story ↓
Figures from the Office for National Statistics, the UK's official counter, published on 6 October, show 1.1 million people in Great Britain who never smoked now use e-cigarettes.
3 of 100
never-smokers in Great Britain who now vape
That is 2.9% of never-smokers, up from 1.5% in 2021.
Fewer than one UK adult in ten now smokes, 4.9 million people, the lowest share on record.
Why it matters
Vapes are less harmful than cigarettes and help smokers stop, but their long-term effects are not known, so the NHS says non-smokers should never vape.
Why it matters
From the new year, selling tobacco to anyone born on or after 1 January 2009 will be banned for life in the UK.
How it works
A vape helps a smoker because it replaces cigarettes, but a person who never smoked has no cigarette risk for it to remove, only the vape's own.
The idea, in story 1: What a treatment is worth depends on the risk it takes away →Who gains
Vape sellers in Great Britain
About 1.1 million of their users never smoked, so that part of their trade does not come from helping smokers stop.
Nobody knows yet
What vaping does to people who never smoked, over many years.
The NHS says the long-term effects of vaping are not yet clear, while 1.1 million people in Great Britain who never smoked now vape.
Good news
Fewer than one adult in ten in the UK now smokes, the lowest share on record. Among 18 to 24 year olds, smoking fell from 25.7% in 2011 to 7.2% in 2025.
2 sources
A million Britons vape who never smoked
The full story
A million Britons vape who never smoked
Figures from the Office for National Statistics, the UK's official counter, published on 6 October, show 1.1 million people in Great Britain who never smoked now use e-cigarettes.
3 of 100
never-smokers in Great Britain who now vape
Why it matters. Vapes are less harmful than cigarettes and help smokers stop, but their long-term effects are not known, so the NHS says non-smokers should never vape.
Doctors argue over a blood test for many cancers
Swipe up for the story ↑Scroll down for the story ↓
On 23 September a panel advising the FDA backed Galleri, a $949 blood test from the company Grail that looks for signs of many cancers at once.
It voted 6 to 4 that the test works and 7 to 2 that its benefits outweigh its risks.
In a study of 35,000 people the test flagged 287, and about 60% of them turned out to have cancer.
Gilbert Welch, a cancer screening researcher in Boston, urged the FDA not to approve it.
Why it matters
He points out that a 140,000-person trial in England found no fall in late-stage cancers, and a US law passed this year makes Medicare pay for such tests once approved.
Why it matters
Colin Pritchard of the University of Washington says the test may help people at high risk, while false alarms could harm people at low risk.
How it works
A researcher says the test may help people at high cancer risk, while people at low risk mostly face false alarms and the scans and biopsies that follow.
The idea, in story 1: What a treatment is worth depends on the risk it takes away →Who gains
Grail, maker of the Galleri test
If the FDA approves the test, a law passed this year means Medicare must pay for it, at up to $949 a test.
Who pays
People who pay for US health insurance and Medicare
Welch estimates that testing every American over 50 each year would cost $60 billion to $100 billion a year.
Nobody knows yet
Whether the Galleri cancer test saves lives.
The FDA panel backed it, but the 140,000-person NHS trial found no fall in late-stage cancers, and the FDA has not yet decided.
3 sources
Doctors argue over a blood test for many cancers
The full story
Doctors argue over a blood test for many cancers
On 23 September a panel advising the FDA backed Galleri, a $949 blood test from the company Grail that looks for signs of many cancers at once.
Why it matters. He points out that a 140,000-person trial in England found no fall in late-stage cancers, and a US law passed this year makes Medicare pay for such tests once approved.
Oxygen clips drifted from too high to too low
Swipe up for the story ↑Scroll down for the story ↓
A pulse oximeter is a clip that shines light through a finger to estimate how much oxygen the blood carries.
A study of five years of intensive care data at Johns Hopkins Hospital found the same make slowly went from reading too high to reading too low, at higher oxygen levels.
The errors were worse in patients of colour.
Why it matters
A clip that is always wrong by the same amount can be corrected for, but one whose error changes cannot, says Thomas Valley of the University of Colorado.
Why it matters
Masimo, which makes the clips used, says it knows of no change that would explain the drift, and the FDA's draft rules on oximeter bias were still not final in January.
Who pays
Patients of colour in intensive care
Oxygen clips have read too high on darker skin, which can make a patient look healthier than they are.
Nobody knows yet
Why pulse oximeters at Johns Hopkins drifted from too high to too low.
One of the study's authors says he has no idea, and Masimo, the maker, says it knows of no change in its sensors or software.
2 sources
Oxygen clips drifted from too high to too low
The full story
Oxygen clips drifted from too high to too low
A pulse oximeter is a clip that shines light through a finger to estimate how much oxygen the blood carries.
Why it matters. A clip that is always wrong by the same amount can be corrected for, but one whose error changes cannot, says Thomas Valley of the University of Colorado.
A US health survey may drop disability questions
Swipe up for the story ↑Scroll down for the story ↓
The National Health Interview Survey has tracked Americans' health since 1957 and is run by the CDC's statistics centre.
A redesign proposed in August would cut the adult questions from 482 to 150.
It drops questions on hearing aids, tiredness, thinking and wheelchairs, though more than a quarter of Americans have a disability.
The redesign is for the 2028 survey, and public comments close on 20 October.
Why it matters
Researchers say the survey may already miss 75% of people with intellectual and developmental disabilities, who have much higher rates of heart disease, diabetes and obesity.
Why it matters
The US health department said the changes are meant to lower the cost of collecting data.
What's really going on
In the US, the CDC is not promoting flu shots as flu starts early in the West, and it plans to drop many disability questions from its main health survey.
Who gains
The US health department's budget
Cutting the survey's adult questions from 482 to 150 lowers the cost of collecting data, it says.
Who pays
Americans with intellectual and developmental disabilities
A survey that may already miss 75% of them would ask even less about how they live.
3 sources
A US health survey may drop disability questions
The full story
A US health survey may drop disability questions
The National Health Interview Survey has tracked Americans' health since 1957 and is run by the CDC's statistics centre.
Why it matters. Researchers say the survey may already miss 75% of people with intellectual and developmental disabilities, who have much higher rates of heart disease, diabetes and obesity.
The WHO sets out care for children with obesity
Swipe up for the story ↑Scroll down for the story ↓
On 7 October the WHO launches two guidelines on how health systems should care for children and teenagers living with obesity.
Until now its treatment advice covered adults, including a guideline on weight-loss drugs issued in December 2025.
In 2024 about 400 million people aged 5 to 19 were overweight, 170 million of them with obesity.
Why it matters
Children with obesity are very likely to stay that way as adults and to get type 2 diabetes and heart disease earlier, the WHO says.
Why it matters
The recommendations themselves are presented at an online launch the same day.
2 sources
The WHO sets out care for children with obesity
The full story
The WHO sets out care for children with obesity
On 7 October the WHO launches two guidelines on how health systems should care for children and teenagers living with obesity.
Why it matters. Children with obesity are very likely to stay that way as adults and to get type 2 diabetes and heart disease earlier, the WHO says.
Hospitals sell longevity check-ups
Swipe up for the story ↑Scroll down for the story ↓
Some of the most prestigious US hospital systems now run cash-pay longevity clinics, which promise to track how a person is ageing.
A STAT reporter tested one at Weill Cornell Medicine in New York, with blood tests, fitness tests and a mask that measures how much oxygen the body can use.
The programmes cost $5,500 to $45,000.
Why it matters
These hospitals pay less tax because they are meant to serve the public, and a Carnegie Mellon University professor said the clinics make them look like businesses.
Why it matters
Others question whether some tests, such as full-body MRI scans, are sound science.
Who gains
Hospitals running longevity clinics
They charge $5,500 to $45,000 in cash while keeping the tax breaks they get for serving the public.
2 sources
Hospitals sell longevity check-ups
The full story
Hospitals sell longevity check-ups
Some of the most prestigious US hospital systems now run cash-pay longevity clinics, which promise to track how a person is ageing.
Why it matters. These hospitals pay less tax because they are meant to serve the public, and a Carnegie Mellon University professor said the clinics make them look like businesses.
Why a hangover can bring a morning of dread
Swipe up for the story ↑Scroll down for the story ↓
Alcohol strengthens GABA, a brain chemical that slows nerve cells down, and weakens glutamate, which keeps the brain alert.
As the alcohol wears off, the brain swings the other way, towards alertness and anxiety.
A 2023 study of over 5,000 UK and Dutch students found 18.3% felt anxious when hungover.
In a 2019 University of Exeter study of 97 drinkers, shy people felt calmer while drinking and much more anxious the next day.
Why it matters
Alcohol also breaks up REM sleep, the dreaming sleep that helps steady emotions, so a hungover brain meets its worries tired.
Why it matters
Studies find that how anxious people feel does not neatly follow how much they drank.
1 source
Why a hangover can bring a morning of dread
The full story
Why a hangover can bring a morning of dread
Alcohol strengthens GABA, a brain chemical that slows nerve cells down, and weakens glutamate, which keeps the brain alert.
Why it matters. Alcohol also breaks up REM sleep, the dreaming sleep that helps steady emotions, so a hungover brain meets its worries tired.
Ten mental health trusts reported over bedroom cameras
Swipe up for the story ↑Scroll down for the story ↓
NHS England told the Lampard Inquiry it had reported ten mental health trusts to the Care Quality Commission, England's health regulator, on 2 October.
A review found they were not asking patients' consent properly before using camera systems such as Oxevision.
These infrared cameras sit in bedrooms and check breathing and pulse without staff going in.
The inquiry is examining the deaths of more than 2,000 people who were in Essex mental health units from 2000 to 2023.
Why it matters
NHS England first heard safety concerns about Oxevision in 2021, and lawyers for bereaved families asked why it took years to act.
Why it matters
The trusts have not been named, and the regulator gives evidence to the inquiry on 7 October.
Who pays
Patients in ten English mental health trusts
A review found their consent to bedroom camera monitoring was not sought in line with NHS England's rules.
Nobody knows yet
Which ten trusts filmed patients without proper consent.
NHS England has not named them, and the regulator has not yet said what it will do.
1 source
Ten mental health trusts reported over bedroom cameras
The full story
Ten mental health trusts reported over bedroom cameras
NHS England told the Lampard Inquiry it had reported ten mental health trusts to the Care Quality Commission, England's health regulator, on 2 October.
Why it matters. NHS England first heard safety concerns about Oxevision in 2021, and lawyers for bereaved families asked why it took years to act.
Calls for an inquiry into Northern Ireland's smear tests
Swipe up for the story ↑Scroll down for the story ↓
Campaigners called the Ladies with Letters renewed calls at Stormont, Northern Ireland's parliament, for a public inquiry into cervical screening.
A scandal at the Southern Health Trust led to 17,500 women being asked to have smear tests rechecked, going back to 2008.
The family of Louise Corbett Gibbons joined them; she died of cervical cancer at 24 in 2008, after a smear said to have been misread.
Her care was in the Belfast trust, outside the scandal.
Why it matters
The campaigners say other trusts may have had the same problems, and they meet Health Minister Robbie Butler next month.
Why it matters
A former health minister ruled out a public inquiry earlier this year.
1 source
Calls for an inquiry into Northern Ireland's smear tests
The full story
Calls for an inquiry into Northern Ireland's smear tests
Campaigners called the Ladies with Letters renewed calls at Stormont, Northern Ireland's parliament, for a public inquiry into cervical screening.
Why it matters. The campaigners say other trusts may have had the same problems, and they meet Health Minister Robbie Butler next month.
Health costs tie with petrol as US voters' worry
Swipe up for the story ↑Scroll down for the story ↓
A poll by KFF, a US health research group, of 1,328 adults from 16 to 21 September found health costs and petrol tied as voters' top money worry.
A quarter were very worried about paying for each, and another third somewhat worried.
Support for a single national health plan, called Medicare for All, reached 66%, the highest since KFF began asking in 2016.
Why it matters
That support fell to 24% when people were told the plan might delay tests and treatment, so the number moves with how the question is put.
Why it matters
The US midterm elections are about a month away.
1 source
Health costs tie with petrol as US voters' worry
The full story
Health costs tie with petrol as US voters' worry
A poll by KFF, a US health research group, of 1,328 adults from 16 to 21 September found health costs and petrol tied as voters' top money worry.
Why it matters. That support fell to 24% when people were told the plan might delay tests and treatment, so the number moves with how the question is put.
Guides kept new mothers in care
Swipe up for the story ↑Scroll down for the story ↓
A Northwestern Medicine study of 405 low-income pregnant patients in Chicago gave some a trained guide, called a patient navigator, from late pregnancy to a year after birth.
The guides booked appointments, arranged transport and childcare, and explained medical information.
A year later 57% had seen a family doctor, against 30%.
Why it matters
Problems that start in pregnancy, such as diabetes and high blood pressure, can affect a mother's health for years, so staying in care matters.
Why it matters
The study appeared in JAMA Health Forum on 2 October.
Good news
In a Chicago study, 96 of every 100 new mothers given a trained guide came to their check-up after the birth, against 80 with usual care.
1 source
Guides kept new mothers in care
The full story
Guides kept new mothers in care
A Northwestern Medicine study of 405 low-income pregnant patients in Chicago gave some a trained guide, called a patient navigator, from late pregnancy to a year after birth.
Why it matters. Problems that start in pregnancy, such as diabetes and high blood pressure, can affect a mother's health for years, so staying in care matters.
Knee shape and torn ligaments
Swipe up for the story ↑Scroll down for the story ↓
The anterior cruciate ligament, or ACL, is a band inside the knee that keeps it stable, and tearing it is a common sports injury.
Young active women tear it more than twice as often as men.
Researchers built computer models of the knees of 168 young active people, half with a torn ACL, and put the same twisting load on each.
The shape of the knee put more force through the ligament in injured people and in women.
Why it matters
It points to part of the risk being built into the shape of a person's knee, not only into how they move.
Why it matters
The authors hope models like these can one day spot knees at risk before an injury.
1 source
Knee shape and torn ligaments
The full story
Knee shape and torn ligaments
The anterior cruciate ligament, or ACL, is a band inside the knee that keeps it stable, and tearing it is a common sports injury.
Why it matters. It points to part of the risk being built into the shape of a person's knee, not only into how they move.
Overfed baby mice lost muscle faster in old age
Swipe up for the story ↑Scroll down for the story ↓
Researchers in Shanghai overfed mice just after birth and followed them into old age.
Their guts kept a weaker layer of protective mucus and fewer of a bacterium called Akkermansia, which makes acetate, a substance that helps muscle cells make energy.
Giving old mice the bacterium or acetate restored their muscle strength.
Why it matters
Moving gut bacteria from overfed mice into other mice passed on the muscle loss, which points at the gut as the link between early feeding and muscle in old age.
Why it matters
The work was done only in mice.
1 source
Overfed baby mice lost muscle faster in old age
The full story
Overfed baby mice lost muscle faster in old age
Researchers in Shanghai overfed mice just after birth and followed them into old age.
Why it matters. Moving gut bacteria from overfed mice into other mice passed on the muscle loss, which points at the gut as the link between early feeding and muscle in old age.
Cardiac arrest survival lagged in Fukushima
Swipe up for the story ↑Scroll down for the story ↓
Researchers studied 188,783 cases in eastern Japan, from 2007 to 2023, of a heart stopping outside hospital in front of family, friends or colleagues.
In the years after rebuilding from the 2011 earthquake and tsunami ended, 3.1% of these people in Fukushima survived a month with a healthy brain.
In other areas the tsunami hit, it was 6.4%.
Why it matters
Survival depends on people nearby starting chest compressions and using a defibrillator, and earlier Japanese studies found both dropped after disasters.
Why it matters
The authors could not tell from their data why Fukushima's gap lasted so long.
1 source
Cardiac arrest survival lagged in Fukushima
The full story
Cardiac arrest survival lagged in Fukushima
Researchers studied 188,783 cases in eastern Japan, from 2007 to 2023, of a heart stopping outside hospital in front of family, friends or colleagues.
Why it matters. Survival depends on people nearby starting chest compressions and using a defibrillator, and earlier Japanese studies found both dropped after disasters.
A cold rinse eased pain after root canals
Swipe up for the story ↑Scroll down for the story ↓
A root canal cleans out the infected inside of a tooth, and pain afterwards is common.
A review pooled 11 randomised trials of rinsing the canal with cold liquid during treatment, called cryotherapy.
Patients given the cold rinse had less pain 6, 24, 48 and 72 hours later, though not at 12 hours.
Only one of the 11 trials was judged at low risk of bias.
Why it matters
The cold is meant to calm swelling around the tip of the tooth's root.
Why it matters
The authors call the benefit short-term and ask for larger, better trials before dentists are told to use it.
1 source
A cold rinse eased pain after root canals
The full story
A cold rinse eased pain after root canals
A root canal cleans out the infected inside of a tooth, and pain afterwards is common.
Why it matters. The cold is meant to calm swelling around the tip of the tooth's root.
Planted documents steered AI health answers
Swipe up for the story ↑Scroll down for the story ↓
Many medical AI tools answer by first searching a library of documents and then writing from what they find.
Researchers in Hong Kong showed that planting five documents per question in that library could change how answers were framed, without changing the facts.
In one test the answers were steered towards a named product.
Why it matters
The attack works on the library of documents rather than on the AI itself, so any tool that reads from a shared collection could be open to it.
Why it matters
It worked on all five AI models and three medical libraries tested.
1 source
Planted documents steered AI health answers
The full story
Planted documents steered AI health answers
Many medical AI tools answer by first searching a library of documents and then writing from what they find.
Why it matters. The attack works on the library of documents rather than on the AI itself, so any tool that reads from a shared collection could be open to it.
Smokers needed more surgery for golfer's elbow
Swipe up for the story ↑Scroll down for the story ↓
Golfer's elbow is pain where the forearm's tendons join the inner side of the elbow.
Researchers searched US insurance records of about 8 million patients from 2007 to 2015 and found 23,573 with it.
People recorded with a tobacco problem had about 60% higher odds of having surgery for it than matched non-users.
Their odds of getting the diagnosis at all were only 5% higher.
Why it matters
The authors say insurance records can show a link but not a cause, so smoking itself may not be what drives the surgery.
Why it matters
Tobacco use was recorded in 30% of those who had surgery, against 24% of all patients with the condition.
1 source
Smokers needed more surgery for golfer's elbow
The full story
Smokers needed more surgery for golfer's elbow
Golfer's elbow is pain where the forearm's tendons join the inner side of the elbow.
Why it matters. The authors say insurance records can show a link but not a cause, so smoking itself may not be what drives the surgery.
AI home exercise for Parkinson's showed no clear gain
Swipe up for the story ↑Scroll down for the story ↓
Researchers in China gave 120 people with early Parkinson's disease, a brain illness that slows movement, an AI-guided exercise programme at home for one, two or three months.
Only 71 finished.
No falls or side effects were recorded, and there was no group without the programme to compare with.
Why it matters
A hint that the longest course helped thinking came from a check done after the trial ended, which the authors say proves nothing yet.
Why it matters
They call for bigger trials planned in advance.
1 source
AI home exercise for Parkinson's showed no clear gain
The full story
AI home exercise for Parkinson's showed no clear gain
Researchers in China gave 120 people with early Parkinson's disease, a brain illness that slows movement, an AI-guided exercise programme at home for one, two or three months.
Why it matters. A hint that the longest course helped thinking came from a check done after the trial ended, which the authors say proves nothing yet.
That's the whole Mind & body day.
21 stories, 44 sources.